Glenmark Life Sciences IPO

Glenmark Life Sciences is launching its IPO. The public offer comprises a fresh issue of equity shares worth Rs. 1,160 crores and offer for sale of 63 lakh equity shares by its parent company Glenmark Pharmaceuticals Ltd.

Don't have a Tradeplus account? Sign up
Date27Jul2021 - 29Jul2021
Price Range (₹)695 – 720
Minimum Order Quantity20
(D)RHPView

Glenmark Life Sciences is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs) catering to chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management, and diabetes, among others. As of December 31, 2020, the company had a portfolio of 120 molecules globally and sold its APIs in India as well as to multiple countries in Europe, North America, Latin America, Japan, and the rest of the world. Read more

Check out some recent financials figures of the company:

Financial Year Ended Revenue (₹ Millions) Profit After Tax (₹ Millions) EPS (₹)
March 2019 886.87  195.59 24.64 
March 2020 1,549.30  313.10 29.04 
March 2021 1,885.98  351.58 32.61 

How do I apply for the Glenmark Life Sciences IPO?

You can apply for the Glenmark Life Sciences IPO using any supported UPI app by following two steps:

  • Enter your bid on rocket
  • Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here to learn more.

×
Open Account Open Account  Call  Chat  Whatsapp
This is a standard alert.

I'm a cool paragraph that lives inside of an even cooler modal. Wins!

This is a standard alert.

I'm a cool paragraph that lives inside of an even cooler modal. Wins!

Mobile Number

+91

Verify Your Mobile

You will receive an OTP on your mobile

Not Received OTP?

Please wait for (0:0) seconds

Message
we have captured your number, we will get back to soon... Okay